IPO & Pre-IPO: Latest IPO News, Insights & Updates

All Categories Account Aggregator Financial Planning Inside Sectors IPO & Pre-IPO Loans & Fixed Income Market Insights & Sectors Monthly AMFI Report Mutual Funds & SIP

Amba Auto Sales IPO: Growth Strong, But What Should Investors Notice?

IPO & Pre-IPO

April 25, 2026

Amba Auto Sales IPO: Growth Strong, But What Should Investors Notice?

When a new IPO opens, especially from a familiar consumer-facing business, it often feels easier to trust. After all, selling two-wheelers or LG appliances is something most people understand. But that familiarity can sometimes hide the deeper questions investors actually need to ask. The Amba Auto Sales & Services IPO is one such case, where […]

Windlas Biotech Buyback 2026: Price, Acceptance Ratio & Returns Explained

IPO & Pre-IPO

April 22, 2026

Windlas Biotech Buyback 2026: Price, Acceptance Ratio & Returns Explained

A buyback announcement like “₹1,000 per share” can quickly catch attention, especially when the stock is trading lower in the market. For many investors, the first instinct is simple: buy now, tender later, and capture the difference. But with the Windlas Biotech buyback 2026, the real question is not just about the premium. It is […]

Wipro’s ₹15,000 Cr Buyback: A Smart Exit or a Debt Trap for Retail Investors?

IPO & Pre-IPO

April 21, 2026

Wipro’s ₹15,000 Cr Buyback: A Smart Exit or a Debt Trap for Retail Investors?

You see a headline like “Wipro announces ₹15,000 crore buyback at ₹250” and it immediately feels like an opportunity. A 23% premium over the current price looks straightforward. Buy shares at ₹202 (as on 20th April, 2026), tender at ₹250, and pocket the difference. But this is exactly where many investors pause. Something feels unclear. […]

Om Power Transmission IPO: What Investors Should Know

IPO & Pre-IPO

April 08, 2026

Om Power Transmission IPO: What Investors Should Know

When a company shows strong profit growth, it naturally attracts attention. The Om Power Transmission IPO is one such case. On the surface, the numbers look encouraging. But like most IPOs, the real picture becomes clearer only when you look beyond the headline figures. Om Power Transmission is a 14-year-old EPC (Engineering, Procurement, and Construction) […]

Safety Controls & Devices IPO 2026: Key Details, Risks & Full Review

IPO & Pre-IPO

April 05, 2026

Safety Controls & Devices IPO 2026: Key Details, Risks & Full Review

The Safety Controls & Devices IPO opens on April 6, 2026, and is attracting attention among investors tracking SME infrastructure companies. On the surface, strong revenue growth and sector diversification make it look promising. But many investors face a common dilemma here. Growth numbers look impressive, yet questions around cash flow, project risks, and government […]

Powerica IPO Review: Business Model, Financials, Risks & Growth Explained

IPO & Pre-IPO

March 23, 2026

Powerica IPO Review: Business Model, Financials, Risks & Growth Explained

When investors come across IPOs in the power or infrastructure space, the first reaction is often mixed. On one side, there is familiarity — electricity, generators, renewable energy. On the other, there is confusion — multiple business segments, technical terms, and financial complexity. Many investors assume that power-related businesses are straightforward because demand seems constant. […]

Amir Chand IPO Review: Business Model, Risks & Financial Analysis Explained

IPO & Pre-IPO

March 23, 2026

Amir Chand IPO Review: Business Model, Risks & Financial Analysis Explained

Many investors come across IPOs from traditional businesses like food processing or exports and feel a sense of familiarity. Rice, for example, is something people understand in daily life. However, when that same product becomes part of a listed business, the dynamics can feel very different. There is often a gap between what investors assume […]

Sai Parenteral IPO Review: Business Model, Financials & Key Risks Explained

IPO & Pre-IPO

March 23, 2026

Sai Parenteral IPO Review: Business Model, Financials & Key Risks Explained

Many investors notice IPO announcements and feel a mix of curiosity and hesitation. On one hand, IPOs appear as early entry opportunities. On the other, the lack of clarity around business models, risks, and financials often creates confusion. This is especially true in sectors like pharmaceuticals, where terms like “CDMO,” “sterile injectables,” or “regulated markets” […]

CMPDI IPO 2026: Price Band, GMP, Financials & Should You Apply?

IPO & Pre-IPO

March 18, 2026

CMPDI IPO 2026: Price Band, GMP, Financials & Should You Apply?

Many investors track IPOs closely, yet understanding what actually matters often feels unclear. Numbers, valuation, and business models can appear scattered without a structured approach. At the same time, IPO discussions frequently shift toward listing expectations or short-term movements. This can distract from what an investor actually needs, which is clarity about the company, its […]